FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Dr Lal PathLabs IPO.
May 7, 2020 11:10:00 AM
They are all coming back.� Dr Lal PathLabs has been growing steadily since its IPO in 2015, when it became the first pure-play diagnostics chain in the country to go public. The number of ...
Published by : ForbesOctober 28, 2022 3:31:00 AM
Jashvik Capital was launched by former TA Associates executive Naresh Patwari and later joined by Metropolis Healthcare and Dr Lal PathLabs� Vijender Singh and Zydus Healthcare�s Anil Matai.
Published by : inc42April 17, 2024 3:31:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarApril 17, 2024 12:25:04 PM
Super specialty diagnostics chain Neuberg Diagnostics has appointed investment bank o3 Capital to raise $100 million from private equity funds, persons aware of the matter told Moneycontrol. According ...
Published by : Moneycontrol on MSNMarch 17, 2024 8:53:00 PM
Dr. Lal PathLabs Limited, one of India's leading diagnostic chains, today announced the appointment of Shankha Banerjee as its new Chief Executive Officer (CEO) and Key Managerial Personnel ...
Published by : MintApril 5, 2024 3:30:00 AM
Dr Lal Pathlabs Ltd share price was up by -0.38% from the previous closing price of ?2,320.05. Who are peers of Dr Lal Pathlabs Ltd? The peers of Dr Lal Pathlabs Ltd are Apollo Hospitals ...
Published by : Business TodayMarch 26, 2024 10:05:00 PM
After a long stretch of stock underperformance, domestic brokerage Kotak Institutional Equities stated in its most recent report that it has double upgraded Dr Lal Pathlabs from Sell to Add with ...
Published by : MintFebruary 5, 2024 9:37:00 AM
As we look forward, we are focused on sharpening the Swasthfit portfolio to make it more condition based, rather than being very generic," says Bharath Uppiliappan, CEO, Dr Lal PathLabs.
Published by : The Economic Times on MSNMarch 7, 2024 2:30:00 AM
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Published by : Wall Street JournalThe Dr Lal PathLabs IPO is proposed to open on December 8, 2015. The IPO application ends on December 10, 2015.
Retail investors can apply in the retail or non-institutional investor category from December 8, 2015 to December 10, 2015. The Dr Lal PathLabs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Dr Lal PathLabs IPO will open for subscription on December 8, 2015. The public issue will close on December 10, 2015.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|